Hormone Resistant Prostate Cancer Terminated Phase 1 Trials for Vorinostat (DB02546)

Also known as: Hormone-Resistant Prostate Cancer

IndicationStatusPhase
DBCOND0038482 (Hormone Resistant Prostate Cancer)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01174199Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate CancerTreatment